NCT04328844 2026-03-30A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersiOncturaPhase 1 Active not recruiting210 enrolled
NCT03297424 2022-07-25A Study of PLX2853 in Advanced Malignancies.Opna Bio LLCPhase 1 Completed49 enrolled